Clinical Trial Update: Anaemia Correction in Haemodialyzed Patients - Comparative Analysis of Two Erythropoietin Stimulating Agents Schedules [Phase 4]

View source ↗

Summary

Phase 4 trial assessing bio-equivalency of two erythropoietin stimulating agent schedules in haemodialysis patients; study withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia in Chronic Kidney Disease
• Chronic Kidney Disease
• Haemodialysis-related Anemia

Snippet

Sponsor: Anemia Working Group Romania | Conditions: Bio-Equivalency of 2 Treatment Schedules in HD Patients | Phase 4 | Status: WITHDRAWN